Stručni rad
Estimated Absorbed Doses from Exposure to a Cyclotron Used in Production of Radiopharmaceuticals
Hrvoje Prpić
; Ruđer Medikol Ciklotron d.o.o., Zagreb, Hrvatska
Alfred Švarc
; Institut Ruđer Bošković, Zagreb, Hrvatska
Robert Bagarić
; Institut Ruđer Bošković, Zagreb, Hrvatska
Sažetak
Nuclear medicine diagnostics and therapy use radiopharmaceuticals, which are pharmaceuticals with radionuclides attached to the biologically active chemical compound with the purpose of marking it in order to follow its metabolism in a living organism. The basic advantage of using radiopharmaceuticals is that they can be monitored by nuclear methods and their deposition in a particular organ or metabolic processes followed over time. Unlike classical radiology, which shows only morphological changes in an
organ, with radiopharmaceuticals we can follow their functional changes. This article discusses estimated occupational exposure of three workers to a cyclotron IBA Cyclone 18/9 at Ruđer Medikol Cyclotron Ltd. (RMC). The total absorbed annual dose is estimated to between 2.95 mSv and 6.77 mSv. The requirement of minimal exposure to any form of radiation – ALARA (“As Low
As Reasonably Achievable.”), recommended by Croatian legislation, is fully met.
Ključne riječi
FDG; positron emitters; radiation protection
Hrčak ID:
60304
URI
Datum izdavanja:
9.11.2010.
Posjeta: 2.283 *